(Q45869133)

17 December 2017

title

Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer (English)

1 reference

17 December 2017

1 reference

1 reference

7

David T Curiel

1 reference

17 December 2017

4

Gene P Siegal

1 reference

17 December 2017

author name string

Masato Yamamoto

1

1 reference

17 December 2017

Julia Davydova

2

1 reference

17 December 2017

Minghui Wang

3

1 reference

17 December 2017

Victor Krasnykh

5

1 reference

17 December 2017

Selwyn M. Vickers

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517802

15 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

17 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S001650850301196X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(03)01196-X

https://api.elsevier.com/content/article/PII:S001650850301196X?httpAccept=text/plain

15 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(03)01196-X

15 March 2024

1 reference

17 December 2017

volume

125

1 reference

17 December 2017

issue

4

1 reference

17 December 2017

page(s)

1203-1218

1 reference

17 December 2017

cites work

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Novel clinical strategies for the treatment of pancreatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Human cancer and gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Gene therapy for cancer: what have we done and where are we going?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Gene transfer into the liver of nonhuman primates with E1-deleted recombinant adenoviral vectors: safety of readministration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Replicative adenoviruses for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

In vivo adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Gene expression in pancreatic adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Induction of the suicide HSV-TK gene by activation of the Egr-1 promoter with radioisotopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Differential expression of the neu oncogene in mouse liver and pancreatic cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Therapeutic strategies using c-erbB-2 promoter-controlled drug activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

The role of COX-2 in intestinal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Cyclooxygenases and lipoxygenases as potential targets for treatment of pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Cyclooxygenase-2 expression in human pancreatic adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Immunohistochemical analysis and in situ hybridization of cyclooxygenase-2 expression in intraductal papillary-mucinous tumors of the pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Characterization of the cyclooxygenase-2 promoter in an adenoviral vector and its application for the mitigation of toxicity in suicide gene therapy of gastrointestinal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Midkine and cyclooxygenase-2 promoters are promising for adenoviral vector gene delivery of pancreatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

A simplified system for generating recombinant adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

The cyclic AMP response element plays an essential role in the expression of the human prostaglandin-endoperoxide synthase 2 gene in differentiated U937 monocytic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

New developments in the virus therapy of cancer: a historical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Studies on the use of viruses in the treatment of carcinoma of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Clinical studies of viruses as antineoplastic agents with particular reference to Egypt 101 virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Induced virus infections in man by the Egypt isolates of West Nile virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

A model for tumor suppression using H-1 parvovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Effective treatment of pancreatic tumors with two multimutated herpes simplex oncolytic viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

G207, modified herpes simplex virus type 1, kills human pancreatic cancer cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Cytogenetic analysis of pancreatic carcinomas: intratumor heterogeneity and nonrandom pattern of chromosome aberrations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

DNA replication of first-generation adenovirus vectors in tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

"Man's best friend": a new model system for cancer therapeutics?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

Expression of cyclooxygenase-2 in prostate carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

inferred from DOI database lookup

7 January 2021

based on heuristic

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2901196-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Molecular mechanisms of oncogenesis

9

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(03)01196-X

The molecular basis of adenovirus pathogenesis

15 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(03)01196-X

Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy

15 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(03)01196-X

Analysis of the tissue-specific promoter of the MUC1 gene.

15 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(03)01196-X

Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer

15 March 2024

40

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(03)01196-X

Overexpression of cyclooxygenase-2 in carcinoma of the pancreas

15 March 2024

42

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(03)01196-X

Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications

15 March 2024

44

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(03)01196-X

Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli.

15 March 2024

50

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(03)01196-X

A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy

15 March 2024

76

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(03)01196-X

A New Animal Model for Human Respiratory Tract Disease Due to Adenovirus

15 March 2024

78

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(03)01196-X

Expression of cyclooxygenase-2 in human lung carcinoma

15 March 2024

80

1 reference

https://api.crossref.org/works/10.1016/S0016-5085(03)01196-X

15 March 2024

Identifiers

1 reference

17 December 2017

release_wdet2zfbwnb35ocsfnxgcy7pvy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wdet2zfbwnb35ocsfnxgcy7pvy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

17 December 2017